Aspirin and PPAR-α activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Barnes, 1997, NF-kB—a pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med., 336, 1066, 10.1056/NEJM199704103361506
Collins, 1995, Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers, FASEB J., 9, 899, 10.1096/fasebj.9.10.7542214
Cyrus, 2002, Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice, Circulation, 106, 1282, 10.1161/01.CIR.0000027816.54430.96
Delerive, 1999, PPAR-α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1, J. Biol. Chem., 274, 32048, 10.1074/jbc.274.45.32048
Delerive, 2000, Induction of IkBa expression as a mechanism contributing to the anti-inflammatory activities of PPAR-α activators, J. Biol. Chem., 275, 36703, 10.1074/jbc.M004045200
Delerive, 2001, Peroxisome proliferator-activated receptors in inflammation control, J. Endocrinol., 169, 453, 10.1677/joe.0.1690453
Deplanque, 2003, Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment, J. Neurosci., 23, 6264, 10.1523/JNEUROSCI.23-15-06264.2003
Dobrian, 1995, Irreversibility glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects, Biochim. Biophys. Acta, 1270, 26, 10.1016/0925-4439(94)00068-2
Dragomir, 2004, Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells, J. Diabetes Its Complicat., 18, 289, 10.1016/j.jdiacomp.2004.03.003
Edgell, 1983, Permanent cell line expressing human factor VIII-related antigen established by hybridization, Proc. Natl. Acad. Sci. U.S.A., 80, 3734, 10.1073/pnas.80.12.3734
Edgell, 1990, Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926, In Vitro Cell. Dev. Biol., 26, 1167, 10.1007/BF02623694
El Midaoui, 2002, Prevention of hyper-tension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats, J. Hypertens., 20, 1407, 10.1097/00004872-200207000-00028
Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for PPAR-α and δ, Proc. Natl. Acad. Sci. U.S.A., 94, 4312, 10.1073/pnas.94.9.4312
Fuster, 1993, Aspirin as a therapeutic agent in cardiovascular disease, Circulation, 87, 659, 10.1161/01.CIR.87.2.659
Ha, 2002, Role of high glucose-induced NF-kB activation in MCP-1 expression by mesangial cells, J. Am. Soc. Nephrol., 13, 894, 10.1681/ASN.V134894
Hundal, 2002, Mechanism by which high dose aspirin improves glucose metabolism in type 2 diabetes, J. Clin. Invest., 109, 1321, 10.1172/JCI0214955
Husain, 1998, Aspirin improves endothelial dysfunction in atherosclerosis, Circulation, 97, 716, 10.1161/01.CIR.97.8.716
Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in culture vascular cells, Diabetes, 49, 1939, 10.2337/diabetes.49.11.1939
Inoue, 2001, The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells, Metabolism, 50, 3, 10.1053/meta.2001.19415
Karin, 1995, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem., 270, 16483, 10.1074/jbc.270.28.16483
Kim, 1994, Evidence that glucose increases adhesion to human aortic endothelial cells, Diabetes, 43, 1103, 10.2337/diab.43.9.1103
Kopp, 1994, Inhibition of NF-kappa B by sodium sal-icylate and aspirin, Science, 265, 956, 10.1126/science.8052854
Lakshminarayanan, 2001, Reactive oxygen intermediates induce MCP-1 in vascular endothelium after brief ischemia, Am. J. Pathol., 159, 1301, 10.1016/S0002-9440(10)62517-5
Li, 2002, Essential role of the NADPH oxidase sub-unit p47 phox in endothelial cells superoxide production in response to phorbol ester and TNF alpha, Circ. Res., 90, 143, 10.1161/hh0202.103615
Lu, 1998, Abnormalities in monocyte recruitment and cytokine expression in MCP-1-deficient mice, J. Exp. Med., 187, 601, 10.1084/jem.187.4.601
Madej, 1998, Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb, Int. J. Clin. Pharmacol. Ther., 36, 345
Manduteanu, 1999, High glucose concentrations enhance monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD-18, Endothelium, 6, 315, 10.3109/10623329909078498
Manduteanu, 2003, Effect of enoxaparin on high glucose-induced activation of endothelial cells, Eur. J. Pharmacol., 477, 269, 10.1016/j.ejphar.2003.08.016
Martin, 1997, Cytokine induction of MCP-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1, Eur. J. Immunol., 27, 1091, 10.1002/eji.1830270508
Martin-Nizard, 2002, Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells, J. Cardiovasc. Pharmacol., 40, 822, 10.1097/00005344-200212000-00003
Marx, 1999, PPAR-α activators inhibit cytokine-induced VCAM-1 expression in human endothelial cells, Circulation, 99, 3125, 10.1161/01.CIR.99.24.3125
Mohazzab, 1999, NADH oxidoreductase is a major source of superoxide anion in bovine coronary endothelium, Am. J. Physiol., 1266, H319
Monobe, 2001, Effects of low-dose aspirin on endothelial function in hypertensive patients, Clin. Cardiol., 24, 705, 10.1002/clc.4960241104
Muller, 1997, Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates, Methods, 11, 301, 10.1006/meth.1996.0424
Pasceri, 2001, Modulation of C-reactive protein-mediated MCP-1 induction in human endothelial cells by anti-therosclerosis drugs, Circulation, 103, 2531, 10.1161/01.CIR.103.21.2531
Pieper, 1997, Activation of NF-kB in cultured endothelial cells by increase glucose concentration: prevention by calphostin C, J. Cardiovasc. Pharmacol., 30, 528, 10.1097/00005344-199710000-00019
Poddar, 2001, Homocysteine induces expression and secretion of MCP-1 and IL-8 in human aortic endothelial cells, Circulation, 103, 2717, 10.1161/01.CIR.103.22.2717
Poynter, 1998, Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses NF-kB signaling and reduces inflammatory cytokine production in aging, J. Biol. Chem., 273, 32833, 10.1074/jbc.273.49.32833
Ranke, 1993, Dose-dependent effect of aspirin on carotid atherosclerosis, Circulation, 87, 1873, 10.1161/01.CIR.87.6.1873
Rovin, 1997, Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status, Cytokine, 9, 178, 10.1006/cyto.1996.0152
Shin, 2002, The role of chemokines in human cardiovascular pathology: enhanced biological insights, Atherosclerosis, 160, 91, 10.1016/S0021-9150(01)00571-8
Shyy, 1995, The cis-acting phorbol ester “12-O tetradecanoylphorbol 13-acetate”-responsive element is involved in shear stress-induced MCP-1 gene expression, Proc. Natl. Acad. Sci. U.S.A., 92, 8069, 10.1073/pnas.92.17.8069
Sica, 1990, Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumour necrosis factor, J. Immunol., 144, 3034, 10.4049/jimmunol.144.8.3034
Simionescu, 1986, Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit, Am. J. Pathol., 123, 109
Simionescu, 1996, Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipidemic-hyperglycemic hamster, Am. J. Pathol., 148, 997
Staels, 1998, Activation of human aortic smooth-muscle cells is inhibited by PPAR but not by PPAR activators, Nature, 393, 790, 10.1038/31701
Takaishi, 2003, High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells, Biochem. Biophys. Res. Commun., 305, 122, 10.1016/S0006-291X(03)00712-5
Takeya, 1993, Detection of MCP-1 in human atherosclerotic lesions by an anti-MCP-1 monoclonal antibody, Human Pathol., 24, 534, 10.1016/0046-8177(93)90166-E
Teissier, 2004, Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties, Circ. Res., 10, 1174, 10.1161/01.RES.0000150594.95988.45
Thun, 1993, Aspirin use and risk of fatal cancer, Cancer Res., 53, 1322
Ungvari, 2003, Increased superoxide production in coronary arteries in hyperhomocysteinemia. Role of TNF-α, NAD(P)H oxidase, and inducible nitric oxide synthase, ATVB, 23, 418, 10.1161/01.ATV.0000061735.85377.40
Yamamoto, 2000, Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 a loop, J. Immunol., 164, 6174, 10.4049/jimmunol.164.12.6174
Yamamoto, 2001, High expression and auto-induction of monocyte chemoattractant protein-1 in scleroderma fibroblasts, Eur. J. Immunol., 31, 2936, 10.1002/1521-4141(2001010)31:10<2936::AID-IMMU2936>3.0.CO;2-0